
    
      The study investigates T2DM patients who have not had surgery or cardiac event in the last 3
      months, between the ages of 40 and 64 years, with T2DM diagnosis between the last 1 and 10
      years and oral antidiabetic therapy for at least 1 The study design is a single-blinded
      randomized, controlled study, and was conducted in the Diabetes Polyclinic of the Istanbul
      University Medical Faculty Hospital.

      Patients randomly assigned to the intervention group, in addition to traditional treatment
      received three to four informative SMS messages per week during the 6-month period, while the
      control group was followed in accordance with the traditional treatment schedule.
    
  